Categories: Research

Cancer, fundamentally, is a problem of too much growth. For decades, health care providers have tried and failed to slow tumor growth using drugs that interfere with a particular signaling pathway, called PI3K, which is known to operate in proliferating cancer cells.

Health at the molecular level: Decoding cellular signals, A trigger for tissue repair, Seeding tomorrow’s science. The future of custom care: Tracking cancer drug resistance, Treating malaria and tuberculosis, Quantitative Biosciences Institute’s culture of inclusivity, The genetics of asthma....

In BPS 115, (Genetics and Pharmacogenetics), first year PharmD students study themselves at a genetic level using pharmacogenetic testing, and volunteer to share their data with each other. Data is aggregated for selected drug metabolizing genes-of-interest.

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Yiqi Cao, a bioengineering PhD candidate, detailed a promising solution she developed for a heart stent that doesn’t trigger scar tissue buildup.

The UCSF Asthma Collaboratory celebrates 20 years of research on genetic factors in asthma.

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

Ten finalists battled for the Grad Slam Championship on 3/22/18. The competition was stiff, the crowd was raucous; but in the end, two BioEs swept the awards.

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

“Whole genome sequencing of pharmacogenetic drug response in racially diverse children with asthma” has been published by the American Journal of Respiratory and Critical Care Medicine (ARJCCM). “This is a huge win for the NHLBI’s TOPMed program, UCSF, and our lab,” said senior author Esteban G....